Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-05-16

FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for an ibuprofen product manufactured by Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

SUPPL AP for IBUPROFEN (IBUPROFEN)